MiR-330 exerts a negative regulatory effect on vav guanine nucleotide exchange factor 1 (VAV1) via the MAPK signaling pathway, which promotes Aβ generation in the AD brain (Zhou et al., 2018). The gene discussed is VAV1; the disease is Alzheimer disease.